These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33404849)

  • 1. Mouse NTCP-Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice.
    Russell LE; DeGorter MK; Ho RH; Leake BF; Schmerk CL; Mansell SE; Kim RB
    AAPS J; 2021 Jan; 23(1):17. PubMed ID: 33404849
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin.
    Bi YA; Qiu X; Rotter CJ; Kimoto E; Piotrowski M; Varma MV; Ei-Kattan AF; Lai Y
    Biopharm Drug Dispos; 2013 Nov; 34(8):452-61. PubMed ID: 23996477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
    Slijepcevic D; Kaufman C; Wichers CG; Gilglioni EH; Lempp FA; Duijst S; de Waart DR; Elferink RP; Mier W; Stieger B; Beuers U; Urban S; van de Graaf SF
    Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).
    Greupink R; Dillen L; Monshouwer M; Huisman MT; Russel FG
    Eur J Pharm Sci; 2011 Nov; 44(4):487-96. PubMed ID: 21945488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
    Choi MK; Shin HJ; Choi YL; Deng JW; Shin JG; Song IS
    Xenobiotica; 2011 Jan; 41(1):24-34. PubMed ID: 20946088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice.
    Slijepcevic D; Roscam Abbing RLP; Katafuchi T; Blank A; Donkers JM; van Hoppe S; de Waart DR; Tolenaars D; van der Meer JHM; Wildenberg M; Beuers U; Oude Elferink RPJ; Schinkel AH; van de Graaf SFJ
    Hepatology; 2017 Nov; 66(5):1631-1643. PubMed ID: 28498614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.
    Pan W; Song IS; Shin HJ; Kim MH; Choi YL; Lim SJ; Kim WY; Lee SS; Shin JG
    Xenobiotica; 2011 Jun; 41(6):501-10. PubMed ID: 21341987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Functional Characterization and in Silico Prediction of Rare Genetic Variation in the Bile Acid and Drug Transporter, Na
    Russell LE; Zhou Y; Lauschke VM; Kim RB
    Mol Pharm; 2020 Apr; 17(4):1170-1181. PubMed ID: 32101444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.
    Fujino H; Saito T; Ogawa S; Kojima J
    J Pharm Pharmacol; 2005 Oct; 57(10):1305-11. PubMed ID: 16259759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na
    Yu D; Zhang H; Lionarons DA; Boyer JL; Cai SY
    Am J Physiol Regul Integr Comp Physiol; 2017 Apr; 312(4):R477-R484. PubMed ID: 28077388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg).
    Li H; Deng M; Guo L; Qiu JW; Lin GZ; Long XL; Xiao XM; Song YZ
    Mol Med Rep; 2019 Dec; 20(6):4915-4924. PubMed ID: 31661128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Na+/taurocholate cotransporting polypeptide (NTCP) c.800C > T polymorphism on rosuvastatin pharmacokinetics in Chinese healthy males.
    Lou XY; Zhang W; Wang G; Hu DL; Guo D; Tan ZR; Zhou HH; Chen Y; Bao HH
    Pharmazie; 2014 Oct; 69(10):775-9. PubMed ID: 25985569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Bile Acid Transporter SLC10A1 in Liver Targeting of the Lipid-Lowering Thyroid Hormone Analog Eprotirome.
    Kersseboom S; van Gucht ALM; van Mullem A; Brigante G; Farina S; Carlsson B; Donkers JM; van de Graaf SFJ; Peeters RP; Visser TJ
    Endocrinology; 2017 Oct; 158(10):3307-3318. PubMed ID: 28938430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solute carrier family 10 (SLC10): beyond bile acid transport.
    Claro da Silva T; Polli JE; Swaan PW
    Mol Aspects Med; 2013; 34(2-3):252-69. PubMed ID: 23506869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic bile acid transporters Ntcp and Bsep expression.
    Cheng X; Buckley D; Klaassen CD
    Biochem Pharmacol; 2007 Dec; 74(11):1665-76. PubMed ID: 17897632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics study of the metabolic changes in hepatoblastoma cells in response to NTCP/SLC10A1 overexpression.
    Wang J; Tian R; Shan Y; Li J; Gao H; Xie C; Ma Y; Wu Y; Ji B; Gu S; Xu M
    Int J Biochem Cell Biol; 2020 Aug; 125():105773. PubMed ID: 32450267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.
    Andrejko KM; Raj NR; Kim PK; Cereda M; Deutschman CS
    Shock; 2008 Apr; 29(4):490-6. PubMed ID: 17724432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.